Vienna Insurance Group’s Syndax Pharmaceuticals SNDX Stock Holding History

Vienna Insurance Group’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.67M	Hold	200,000	–	–	1.78%	21
2025 Q4	$4.2M	Hold	200,000	–	–	2.05%	19
2025 Q3	$3.08M	Hold	200,000	–	–	1.82%	19
2025 Q2	$1.87M	Hold	200,000	–	–	1.18%	17
2025 Q1	$2.46M	Buy	+200,000	New	+$2.82M	1.34%	18

Other funds holding SNDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Vienna Insurance Group's SNDX Position: Q1 2026 in Review

Vienna Insurance Group held its Syndax Pharmaceuticals (SNDX) position steady in Q1 2026 at 200,000 shares worth $4.67M. The position accounts for 1.78% of the portfolio, ranked #21.

Vienna Insurance Group first reported a position in SNDX in Q1 2025 and has held it in 5 quarters since. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

Vienna Insurance Group held 200,000 shares of Syndax Pharmaceuticals worth $4.67M as of Q1 2026.
Vienna Insurance Group left its Syndax Pharmaceuticals share count unchanged in Q1 2026.
Syndax Pharmaceuticals made up 1.78% of Vienna Insurance Group's portfolio in Q1 2026, its #21 holding.
Vienna Insurance Group first reported a position in Syndax Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Vienna Insurance Group's 13F filing for Q1 2026, filed 5 May 2026.